Related Experiment Videos
Mechanisms of thrombosis in hyperhomocysteinemia
1Veterans Affairs Medical Center and Department of Internal Medicine, The University of Iowa, Iowa City 52242, USA.
Insights
High homocysteine levels (hyperhomocysteinemia) increase the risk of blood clots, like stroke and heart attack. While B vitamins may help, their benefit for preventing thrombosis is unproven.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Vascular Biology
Background:
- Hyperhomocysteinemia is a recognized risk factor for thrombotic vascular events, including stroke, myocardial infarction, and venous thrombosis.
- In vitro studies suggest homocysteine exerts prothrombotic effects on vascular endothelium and smooth muscle.
- Animal and human studies confirm an association between moderate hyperhomocysteinemia and vascular dysfunction.
Purpose of the Study:
- To review the role of hyperhomocysteinemia in vascular dysfunction and thrombosis.
- To explore proposed mechanisms linking homocysteine metabolism dysregulation to impaired vascular function.
- To discuss the potential therapeutic benefits of B vitamin supplementation in managing hyperhomocysteinemia-associated thrombosis.
Main Methods:
- Review of in vitro cell culture studies.
- Analysis of recent animal and human studies.
- Examination of current models of homocysteine metabolism and vascular function.
Main Results:
- Homocysteine demonstrates prothrombotic effects on vascular cells.
- Moderate hyperhomocysteinemia is linked to vascular dysfunction in vivo.
- Mechanisms may involve oxidant stress or altered cellular methylation.
Conclusions:
- Hyperhomocysteinemia is a significant risk factor for thrombotic events.
- While B vitamins can lower homocysteine levels, their clinical efficacy in preventing thrombosis remains unproven.
- Further research is needed to establish the therapeutic benefit of B vitamins for patients with thrombosis.
Abstract:
Hyperhomocysteinemia is now recognized as a common risk factor for thrombotic vascular events such as stroke, myocardial infarction, and venous thrombosis. Studies of cultured cells in vitro indicate that homocysteine has prothrombotic effects on the endothelium and vascular smooth muscle. An association between moderate hyperhomocysteinemia and vascular dysfunction was confirmed in recent studies in animals and humans. Current models propose that dysregulation of homocysteine metabolism may impair vascular function through mechanisms involving oxidant stress or altered cellular methylation. Although moderate hyperhomocysteinemia can be treated effectively by administration of folic acid and other B vitamins, the clinical benefit of this therapeutic approach has not been proven in patients with thrombosis.